Ovid Therapeutics Inc Says May Offer And Sell Shares Of Our Common Stock Having An Aggregate Offering Price Of Up To $75M From Time To Time
Portfolio Pulse from Benzinga Newsdesk
Ovid Therapeutics Inc. has announced through an SEC filing that it may offer and sell shares of its common stock up to an aggregate offering price of $75 million from time to time.
November 15, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ovid Therapeutics Inc. may periodically sell common stock worth up to $75M, which could dilute current shareholders' equity and potentially depress the stock price in the short term.
The announcement of a potential sale of common stock usually leads to concerns about equity dilution among existing shareholders. This can often result in a negative short-term reaction in the stock market as investors adjust to the increased supply of shares and the potential for reduced earnings per share.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100